reviewTop 1% cited
Functional amyloid – from bacteria to humans
Trends in Biochemical Sciences · 2007 · Vol. 32(5) · pp. 217–224
Douglas M. Fowler✉(Scripps Research Institute)Atanas V. Koulov(Scripps Research Institute)William E. Balch(Scripps Research Institute)Jeffery W. Kelly(Scripps Research Institute)
Prion Diseases and Protein MisfoldingAlzheimer's disease research and treatmentsAmyloidosis: Diagnosis, Treatment, OutcomesAmyloid (mycology)Context (archaeology)BacteriaAmyloid diseaseBiologyBiochemistryChemistryDiseaseAmyloid βAmyloid fibril
MeSH terms
AmyloidAnimalsBacteriaFungiHemostasisHumansMelaninsModels, BiologicalProtein Conformation
Funding
- National Science Foundation
- Annenberg Foundation
- Cystic Fibrosis Foundation
- Lita Annenberg Hazen Foundation
- National Institutes of Health
- Skaggs Institute for Chemical Biology, Scripps Research Institute
Citations
1,042
FWCI
19.84
field-weighted impact
References
79
Percentile
100%
vs. same field & year
Citations per year
Cited by
On the lag phase in amyloid fibril formation
Physical Chemistry Chemical Physics · 2015 · 751 citations
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Nature Structural & Molecular Biology · 2008 · 1,407 citations
The amyloid state and its association with protein misfolding diseases
Nature Reviews Molecular Cell Biology · 2014 · 2,362 citations
Fuzzy complexes: polymorphism and structural disorder in protein–protein interactions
Trends in Biochemical Sciences · 2007 · 1,072 citations
References
Functional Amyloid Formation within Mammalian Tissue
PLoS Biology · 2005 · 812 citations
Protein Misfolding, Functional Amyloid, and Human Disease
Annual Review of Biochemistry · 2006 · 6,373 citations
Prions
Proceedings of the National Academy of Sciences · 1998 · 5,339 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.